HealthEquity, Inc. (HQY) Stock Rating Reaffirmed by Robert W. Baird
HealthEquity, Inc. (NASDAQ:HQY)‘s stock had its “hold” rating reiterated by equities researchers at Robert W. Baird in a report released on Thursday.
Several other equities analysts have also recently commented on the company. BidaskClub upgraded HealthEquity from a “strong sell” rating to a “sell” rating in a research note on Friday, September 15th. Oppenheimer Holdings, Inc. reiterated a “buy” rating and set a $61.00 target price on shares of HealthEquity in a research note on Wednesday, September 6th. Cantor Fitzgerald reiterated a “buy” rating and set a $56.00 target price on shares of HealthEquity in a research note on Tuesday, September 5th. Zacks Investment Research cut HealthEquity from a “buy” rating to a “hold” rating in a research note on Friday, August 4th. Finally, TheStreet upgraded HealthEquity from a “c” rating to a “b” rating in a research note on Monday, July 31st. One equities research analyst has rated the stock with a sell rating, two have assigned a hold rating and eight have given a buy rating to the company’s stock. The stock currently has an average rating of “Buy” and an average price target of $56.50.
Shares of HealthEquity (HQY) opened at 47.35 on Thursday. The firm has a market cap of $2.86 billion, a PE ratio of 70.25 and a beta of 1.75. The firm’s 50-day moving average is $44.62 and its 200-day moving average is $46.01. HealthEquity has a 12-month low of $30.34 and a 12-month high of $54.95.
HealthEquity (NASDAQ:HQY) last released its earnings results on Tuesday, September 5th. The company reported $0.27 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $0.14 by $0.13. The company had revenue of $56.90 million during the quarter, compared to analysts’ expectations of $55.66 million. HealthEquity had a return on equity of 13.93% and a net margin of 20.27%. The business’s revenue was up 28.7% on a year-over-year basis. During the same period in the prior year, the business posted $0.16 EPS. Equities analysts expect that HealthEquity will post $0.71 earnings per share for the current fiscal year.
In related news, VP Ashley Dreier sold 10,000 shares of the company’s stock in a transaction that occurred on Wednesday, September 6th. The stock was sold at an average price of $45.50, for a total transaction of $455,000.00. Following the sale, the vice president now directly owns 15,652 shares of the company’s stock, valued at approximately $712,166. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, insider Stephen Neeleman sold 8,500 shares of the company’s stock in a transaction that occurred on Monday, July 17th. The shares were sold at an average price of $50.83, for a total value of $432,055.00. Following the sale, the insider now directly owns 1,000 shares in the company, valued at $50,830. The disclosure for this sale can be found here. Over the last three months, insiders have sold 1,630,567 shares of company stock worth $82,623,514. Corporate insiders own 29.00% of the company’s stock.
Hedge funds and other institutional investors have recently modified their holdings of the business. Vanguard Group Inc. increased its position in HealthEquity by 6.2% in the first quarter. Vanguard Group Inc. now owns 4,115,237 shares of the company’s stock worth $174,691,000 after buying an additional 240,136 shares during the period. Paloma Partners Management Co acquired a new stake in HealthEquity in the first quarter worth $503,000. First Trust Advisors LP increased its position in HealthEquity by 17.0% in the second quarter. First Trust Advisors LP now owns 94,283 shares of the company’s stock worth $4,698,000 after buying an additional 13,676 shares during the period. Royce & Associates LP increased its position in HealthEquity by 18.0% in the second quarter. Royce & Associates LP now owns 139,200 shares of the company’s stock worth $6,936,000 after buying an additional 21,200 shares during the period. Finally, Teacher Retirement System of Texas acquired a new stake in HealthEquity in the second quarter worth $200,000. 90.97% of the stock is currently owned by hedge funds and other institutional investors.
HealthEquity Company Profile
HealthEquity, Inc provides a range of solutions for managing healthcare accounts (Health Savings Accounts (HSAs), Health Reimbursement Arrangements (HRAs) and Flexible Spending Accounts (FSAs)) for health plans, insurance companies and third-party administrators. The Company is engaged in technology-enabled services platforms that allow consumers to make healthcare saving and spending decisions.
Receive News & Ratings for HealthEquity Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HealthEquity Inc. and related companies with MarketBeat.com's FREE daily email newsletter.